1. Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon 
A. Arizcorreta, F. Brun, C. Fernández-Gutiérrez, R. García Juárez, F. Guerrero, E. Pérez-Guzmán, J.A. Girón-González 
Clinical Microbiology and Infection 
Volume 10, Issue 12, Pages (December 2004)
DOI: /j x
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Evolution of the median neutrophil count (A), platelet count (B), haemoglobin concentration (C), total lymphocyte count (D) and CD4 lymphocyte count (E) in patients with HIV–HCV co-infection receiving therapy with interferon plus ribavirin. Values represent the median of the values attained at each point of evolution. Continuous line, overall group (n = 21); dashed line, patients treated with pegylated interferon (n = 11); dotted line, patients treated with standard interferon (n = 10).
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions